Afrah Fatthi Salama
Overview
Explore the profile of Afrah Fatthi Salama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elmetwalli A, El-Sewedy T, Hassan M, Abdel-Monem M, Hassan J, Ismail N, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39718609
Gold nanoparticles (AuNPs) have emerged as promising candidates for cancer therapy due to their unique physicochemical properties and biocompatibility. In this study, we investigate the synthesis, characterization, and therapeutic potential...
2.
Salama A, El-Far A, Anbar E, El-Naggar S, Elshazli R, Elmetwalli A
Med Oncol
. 2024 Apr;
41(5):121.
PMID: 38647732
No abstract available.
3.
Salama A, El-Far A, Anbar E, El-Naggar S, Elshazli R, Elmetwalli A
Med Oncol
. 2024 Jan;
41(2):57.
PMID: 38228916
Ginger (Gin) has numerous therapeutic properties. One of Gin's most potent components is 6-gingerol, a naturally occurring phenol. This study aimed to investigate the therapeutic impact of gingerol and/or sorafenib...
4.
El-Sewedy T, Salama A, Mohamed A, Elbaioumy N, El-Far A, Albalawi A, et al.
BMC Complement Med Ther
. 2023 Sep;
23(1):329.
PMID: 37726740
Background: Sorafenib (Sor) is the only approved multikinase inhibitor indicated for the treatment of HCC. Previous studies have shown that amygdalin (Amy) possesses anticancer activities against several cancer cell lines;...
5.
Elmetwalli A, Hashish S, Hassan M, El-Magd M, El-Naggar S, Tolba A, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 May;
396(11):3087-3099.
PMID: 37160480
Cancer cells can become resistant to existing treatments over time, so it is important to develop new treatments that target different pathways to stay ahead of this resistance. Many cancer...
6.
Elmetwalli A, Diab T, Albalawi A, El-Naggar S, El-Far A, Ghedan A, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 May;
396(10):2501-2517.
PMID: 37145126
Hepatocellular carcinoma (HCC) is a serious and potentially fatal form of cancer associated with liver damage. New anticancer drugs are increasingly needed due to the increasing number of cancer cases...
7.
Elmetwalli A, Allam N, Hassan M, Albalawi A, Shalaby A, El-Said K, et al.
BMC Microbiol
. 2023 Apr;
23(1):119.
PMID: 37120512
Environmental contamination by phenol has been reported in both aquatic and atmospheric environments. This study aimed to separate and purify the peroxidase enzyme from bacteria that degrade phenol from wastewater...
8.
El-Shehawy A, Elmetwalli A, El-Far A, Mosallam S, Salama A, Babalghith A, et al.
BMC Complement Med Ther
. 2023 Mar;
23(1):69.
PMID: 36870998
Background: Traditional herbal medicine has been used for centuries to cure many pathological disorders, including cancer. Thymoquinone (TQ) and piperine (PIP) are major bioactive constituents of the black seed (Nigella...
9.
Attia A, Salama A, Eldiasty J, Mosallam S, El-Naggar S, El-Magd M, et al.
Sci Rep
. 2022 Apr;
12(1):6494.
PMID: 35444229
The burden of cancer diseases is increasing every year, therefore, the demands to figure out novel drugs that can retain antitumor properties have been raised. This study aimed to investigate...